4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Neumora Therapeutics, Inc. (NMRA) operates in the Biotechnology industry and is headquartered in Watertown, United States with about 92 employees. Its market capitalization is roughly $305 million. In the fiscal year ended 2025-12-31, NMRA reported $0M in revenue and ($237M) in net income.
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($241M) | ($264M) | ($252M) | ($136M) |
| Net Income | ($237M) | ($244M) | ($236M) | ($131M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($53M) | ($58M) | ($58M) | ($54M) | ($71M) |
| Net Income | ($54M) | ($60M) | ($57M) | ($53M) | ($68M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $191M | $317M | $496M | $426M | — |
| Total Liabilities | $87M | $30M | $27M | $873M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NMRA viewer.
About TickerBase · Data methodology & sources